May 2011 $13 M Issued in a merger or acquisition $10 to $50 million 14
Cell Biosciences Inc.: Private sale, May 2011 × Investors in this round 14 investors had bought by the notice of May 23, 2011: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $13 M of $13 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them, other: "Offering of Series F Preferred Stock (""Series F""), warrants to purchase Common Stock (""Warrants"") and the underlying shares of Common Stock isuable upon conversion of the Series F and upon exerci
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jason Blaine Novi · Executive Officer Timothy Harkness · Executive Officer, Director A. Blaine Bowman · Director David Barker · Director Jack Blaine Nielson · Director James Blaine Woody · Director Ron Blaine Eastman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On a merger: “The Issuer used approximately $9,000,000 of the total amount sold in the offering to purchase all of the outstanding shares of Brightwell Technologies, Inc.”Signed by Timothy Harkness, President and CEO. Source: SEC Form D, newest notice filed May 23, 2011. Read the notice at the SEC .
equity, options SEC Oct 2010 $20 M Issued in a merger or acquisition $10 to $50 million 14
Cell Biosciences Inc.: Private sale, Oct 2010 × Investors in this round 14 investors had bought by the notice of Nov 1, 2010: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $20 M of $21 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: "Offering of Series F Preferred Stock (""Series F""), warrants to purchase Common Stock (""Warrants"") and the underlying shares of Common Stock isuable upon conversion of the Series F and upon exerci
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jason Blaine Novi · Executive Officer Timothy Harkness · Executive Officer, Director A. Blaine Bowman · Director David Barker · Director Jack Blaine Nielson · Director James Blaine Woody · Director James Blair · Director Ron Blaine Eastman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On a merger: “The Issuer used approximately $12.3M of the total amount sold to purchase all of the outstanding shares of Convergent Bioscience Ltd. and $700,000 of the total amount sold to purchase all of the oustanding shares of Convergent Bioscience Services, Inc.”Signed by Timothy Harkness, President and CEO. Source: SEC Form D, newest notice filed Nov 1, 2010. Read the notice at the SEC .
equity SEC Dec 2009 $9 M Issued in a merger or acquisition $2 to $10 million 3
Cell Biosciences Inc.: Private sale, Dec 2009 × Investors in this round 3 investors had bought by the notice of Dec 21, 2009: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $10 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: "Offering of Series E Preferred Stock (""Series E""), and the underlying shares of Common Stock isuable upon conversion of the Series E."
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Jason Blaine Novi · Executive Officer Timothy Harkness · Executive Officer, Director A. Blaine Bowman · Director David Barker · Director Jack Blaine Nielson · Director James Blaine Woody · Director James Blair · Director Julie Blaine Eskay-Eagle · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On a merger: “$5,250,000 of the Issuer's Series E was issued in exchange for outstanding senior notes of target company and $3,999,999 of the Issuer's Series E was issued in connection with a venture capital financing.”Signed by Timothy Harkness, President and CEO. Source: SEC Form D, newest notice filed Dec 21, 2009. Read the notice at the SEC .
equity SEC Oct 2009 $15 M No. 2 $10 to $50 million 10
Cell Biosciences Inc.: Raise no. 2, Oct 2009 × Investors in this round 10 investors had bought by the notice of Nov 12, 2009: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $15 M of $18 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them, other: "Offering of Series D Preferred Stock (the ""Series D""), warrants to purchase Common Stock (the ""Warrants"") and the underlying shares of Common Stock issuable upon exercise of Warrants and upon con
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice James Blaine Novi · Executive Officer Timothy Harkness · Executive Officer, Director A. Blaine Bowman · Director David Barker · Director Jack Blaine Nielson · Director James Blaine Woody · Director James Blair · Director Julie Blaine Eskay-Eagle · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Includes the aggregate exercise price of Warrants (as defined in Item 9)”Signed by Timothy Harkness, President and CEO. Source: SEC Form D, newest notice filed Nov 12, 2009. Read the notice at the SEC .
equity, options SEC Apr 2009 $5 M No. 1 $2 to $10 million 11
Cell Biosciences Inc.: Raise no. 1, Apr 2009 × Investors in this round 11 investors had bought by the notice of Apr 20, 2009: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $11 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity, other: "Offering of Series C Preferred Stock (the ""Series C"") and the underlying shares of Common Stock issuable upon conversion of the Series C."
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in De People named in the notice James Novi · Executive Officer Timothy Harkness · Executive Officer, Director A. Blaine Bowman · Director David Barker · Director Jack Nielson · Director James Blair · Director James Woody · Director Julie Eskay-Eagle · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Timothy Harkness, President and CEO. Source: SEC Form D, newest notice filed Apr 20, 2009. Read the notice at the SEC .
equity SEC